KH902 fusion protein: all 21 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity TherapyRecruitingNCT06717412Not applicableHow we know
- Conbercept Injection in Treatment of Severe Proliferative Diabetic RetinopathyCompletedNCT02816710Phase 4Results postedHow we know
- Biological Changes in Fibrovascular Membranes of Patients With Proliferative Diabetic Retinopathy Following Faricimab InjectionCompletedNCT07144865Not applicableHow we know
- Efficacy and Safety of Conbercept for Diabetic Macular Edema Combined With Severe Non-proliferative Diabetic RetinopathyActive, not recruitingNCT06305143Phase 4How we know
- Effect of Postvitrectomy Proactive Use of Conbercept on Postoperative Complications in PDR PatientsStatus unknownNCT05642793Phase 2How we know
- A Clinical Study on the Efficacy and Safety of VEC Intravenous Chemotherapy Combined With Conbercept Intravitreal Injection in the Treatment of RetinoblastomaStatus unknownNCT04990271Phase 2How we know
- Evaluation of RC28-E Injection in Diabetic Macular EdemaCompletedNCT04782115Phase 2How we know
- Effects of Adding Triamcinolone Acetonide to Conbercept Treatment for Refractory Diabetic Macular Edema (CONTE)Status unknownNCT04627402Not applicableHow we know
- Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line TherapyStatus unknownNCT04555304Phase 2How we know
- Application of Intravitreal Conbercept Injection as a Primary Treatment for Exudative Circumscribed Choroidal HaemangiomaStatus unknownNCT03973125Early Phase 1How we know
- PRP vs PRP+IVC for Severe nPDRStatus unknownNCT03863535Not applicableHow we know
- Safety and Effectiveness of Intravitreal Conbercept for Exudative Circumscribed Choroidal HaemangiomaStatus unknownNCT03571282Early Phase 1How we know
- Intravitreal Conbercept After VitrectomyCompletedNCT03426540Early Phase 1How we know
- The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV)Status unknownNCT03159884Phase 4How we know
- Conbercept in Choroidal Neovascularization Secondary to UveitisStatus unknownNCT02934841Phase 2How we know
- Intravitreal Conbercept for Idiopathic Choroidal NeovascularizationStatus unknownNCT02857517Phase 2How we know
- Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)Status unknownNCT02194634Phase 3How we know
- An Open, Single-center, Safety and Efficacy Study of Conbercept in Patients With Very Low Vision Secondary to Wet Age-related Macular Degeneration (wAMD)Status unknownNCT02098720Phase 2How we know
- Efficacy and Safety of Conbercept in Macular Edema Secondary to Retinal Vein OcclusionStatus unknownNCT01809236Phase 2How we know
- A Randomized, Double-blind, Multicenter, Sham-controlled, Safety and Efficacy Study of Conbercept in Patients With mCNVStatus unknownNCT01809223Phase 3How we know
- Safety and Efficacy by Multiple Injection of KH902 in Patients With Diabetic Macular Edema (DME)CompletedNCT01324869Phase 1/2How we know